Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantation
Author:
Affiliation:
1. Department of Pharmacy University of Wisconsin Hospital and Clinics Madison WI USA
2. Department of Medicine University of Wisconsin‐Madison School of Medicine and Public HealthUniversity of Wisconsin Hospital and Clinics Madison WI USA
Publisher
Wiley
Subject
Infectious Diseases,Transplantation
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13617
Reference27 articles.
1. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
3. Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
4. Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients
5. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol (Maribavir IIR);2024-09-04
2. A call for cytomegalovirus stewardship initiatives in cardiothoracic transplant;JHLT Open;2024-05
3. Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction;Clinical Transplantation;2023-09-27
4. CMV antiviral stewardship: navigating obstacles to facilitate target attainment;Current Opinion in Organ Transplantation;2022-11-03
5. Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard;Transplant Infectious Disease;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3